ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: EC:7.2.2.13; Na(+)/K (+) ATPase alpha-1 subunit; Sodium pump subunit alpha-1; Sodium/potassium-transporting ATPase subunit alpha-1
Storage: 2-8C
Application: Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected Na+/K+ ATPase -1 in Rat Brain Microsomal preparations and in lysates from A431, and A549 cells.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Na+/K+ ATPase -1 in human kidney tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected Na+/K+ ATPase -1 in A431 and MCF-7 cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany